Legend Biotech Files 6-K Report
Ticker: LEGN · Form: 6-K · Filed: Nov 3, 2025 · CIK: 1801198
| Field | Detail |
|---|---|
| Company | Legend Biotech Corp (LEGN) |
| Form Type | 6-K |
| Filed Date | Nov 3, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-k, reporting
TL;DR
Legend Biotech filed a standard 6-K, confirming 20-F annual report filings.
AI Summary
Legend Biotech Corporation filed a Form 6-K on November 3, 2025, to report information as a foreign private issuer. The filing indicates that the company is subject to the reporting requirements of the Securities Exchange Act of 1934 and will file its annual reports under cover of Form 20-F. The company's principal executive office is located at 2101 Cottontail Lane, Somerset, New Jersey.
Why It Matters
This filing is a routine disclosure for foreign private issuers, providing transparency on their reporting obligations and administrative details to the SEC.
Risk Assessment
Risk Level: low — This is a routine administrative filing and does not contain new material financial or operational information.
Key Players & Entities
- Legend Biotech Corporation (company) — Filer of the 6-K report
- 2101 Cottontail Lane, Somerset, New Jersey (location) — Principal executive office address
- November 3, 2025 (date) — Filing date of the 6-K report
- Form 6-K (document) — Type of SEC filing
- Form 20-F (document) — Annual report form for foreign private issuers
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to furnish information to the SEC.
Which annual report form does Legend Biotech Corporation file?
Legend Biotech Corporation files its annual reports under cover of Form 20-F.
What is the filing date of this Form 6-K?
This Form 6-K was filed on November 3, 2025.
Where is Legend Biotech Corporation's principal executive office located?
Legend Biotech Corporation's principal executive office is located at 2101 Cottontail Lane, Somerset, New Jersey.
Is Legend Biotech Corporation a U.S. domestic issuer or a foreign private issuer?
Legend Biotech Corporation is identified as a foreign private issuer.
Filing Stats: 317 words · 1 min read · ~1 pages · Grade level 13.8 · Accepted 2025-11-03 16:01:03
Filing Documents
- f6k_110325.htm (6-K) — 7KB
- exh_991.htm (EX-99.1) — 47KB
- 0001171843-25-006904.txt ( ) — 55KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Legend Biotech Corporation (Registrant) Date: November 3, 2025 /s/ Ying Huang Ying Huang, Ph.D. Chief Executive Officer